Practice Areas
Life Sciences / Healthcare; Crisis Management / Compliance (Internal Investigations, Global Compliance, Whistleblowing); M&A (M&A / Reorganizations / Capital and Business Alliances, Cross-Border M&A, Private Equity, Start-Ups); Intellectual Property (Intellectual Property Transactions, Intellectual Property Disputes); Corporate Law (Corporate Governance)
Career
Background
Doshisha University (LL.B., 2006); Kyoto University Law School (J.D., 2008); Northwestern University School of Law (LL.M. with honors, 2016); Northwestern University School of Law, Kellogg School of Management (Certificate in Business Administration, 2016); Jenner & Block LLP, Chicago (2016-2017); assigned to the Pharmaceutical Bureau (Compliance and Narcotics Division, Pharmaceutical Evaluation Division, and Medical Device Evaluation Division) of the Ministry of Health, Labour and Welfare as a fixed-term government employee (as Legal Adviser) (2017-2020)
Major Activities
Member of Review Committee for Study Regarding Pharmaceutical Regulations on Medical Equipment Programs Utilizing Artificial Intelligence and Other Advanced Technology, Japan Agency for Medical Research and Development(2020-2022); Member of Study Group on Countermeasures against Cannabis and Other Drugs, Ministry of Health, Labour and Welfare(2020-2021); Member of the Advisory Committee (Advisory Committee on Manufacture and Quality Control of Pharmaceutical Products) for Toyama Pharmaceutical Affairs Council (2021); Adviser for The Japan Federation of Medical Devices Associations (2021-); Member of the Toyama Prefecture GMP Inspection Investigative Committee (2021); Member of Legislation Committee, Japan Pharmaceutical Association (2022-); Member of the Board of Experts for the “Consultation Desk for Clinical Research of Medical Equipment,” Japan Association for the Advancement of Medical Equipment (2024-); Member of the Clinical Trial Ethics Review Board, Cancer Institute Hospital Of JFCR (2025-)